Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

149 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Feasibility of Pay for Performance and Transparency Interventions on the Selection and Quality of Observational Management for Patients with Low-Risk Prostate Cancer in the Community Practice.
Gaylis FD, Leapman MS, Ellis SD, Hu S, Cooperberg MR, Loeb S, Chen RC, Cohen ES, Dato PE, Aynehchi S, David R, Topp R, Santomauro B, Ginsburg K, Catalona WJ. Gaylis FD, et al. Among authors: leapman ms. Urol Pract. 2024 Oct 25:101097UPJ0000000000000745. doi: 10.1097/UPJ.0000000000000745. Online ahead of print. Urol Pract. 2024. PMID: 39453985 No abstract available.
Molecular Correlates of Prostate Cancer Visibility on Multiparametric Magnetic Resonance Imaging: A Systematic Review.
Fazekas T, Pallauf M, Kufel J, Miszczyk M, Tsuboi I, Matsukawa A, Laukhtina E, Kardoust Parizi M, Mancon S, Cadenar A, Schulz R, Yanagisawa T, Baboudjian M, Szarvas T, Gandaglia G, Tilki D, Nyirády P, Rajwa P, Leapman MS, Shariat SF. Fazekas T, et al. Among authors: leapman ms. Eur Urol Oncol. 2024 Oct 15:S2588-9311(24)00227-X. doi: 10.1016/j.euo.2024.09.017. Online ahead of print. Eur Urol Oncol. 2024. PMID: 39414421 Free article. Review.
Adaptation of the socioecological model to address disparities in engagement of Black men in prostate cancer genetic testing.
Leader AE, Rebbeck TR, Oh WK, Patel AV, Winer EP, Bailey LO, Gomella LG, Lumpkins CY, Garraway IP, Aiello LB, Baskin ML, Cheng HH, Cooney KA, Ganzak A, George DJ, Halabi S, Hathaway F, Healy C, Kim JW, Leapman MS, Loeb S, Maxwell KN, McNair C, Morgan TM, Prindeville B, Soule HR, Steward WL, Suttiratana SC, Taplin ME, Yamoah K, Fortune T, Bennett K, Blanding-Godbolt J, Gross L, Giri VN. Leader AE, et al. Among authors: leapman ms. BMC Public Health. 2024 Sep 18;24(1):2533. doi: 10.1186/s12889-024-20008-8. BMC Public Health. 2024. PMID: 39289635 Free PMC article.
Risk factors for Gleason score upgrade from prostate biopsy to radical prostatectomy.
Smani S, Sundaresan V, Lokeshwar SD, Choksi AU, Carbonella J, Brito J, Renzulli J, Sprenkle P, Leapman MS. Smani S, et al. Among authors: leapman ms. Explor Target Antitumor Ther. 2024;5(4):981-996. doi: 10.37349/etat.2024.00259. Epub 2024 Jul 30. Explor Target Antitumor Ther. 2024. PMID: 39280242 Free PMC article. Review.
149 results